drugset / Trial / NCT00264654

Long-term Study Of Paroxetine in Women and Men

NCT00264654

Phase 3 Completed 50 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD)

Timeline

Start
2005-10
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule

Indications